Tested Applications
| Positive WB detected in | A431 cells, HepG2 cells, A549 cells, DU 145 cells, HEK-293 cells |
| Positive IP detected in | A549 cells |
| Positive IHC detected in | human lung cancer tissue, human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20243-1-AP targets YES1-Specific in WB, IHC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 |
| Calculated Molecular Weight | 61 kDa |
| Observed Molecular Weight | 61 kDa |
| GenBank Accession Number | NM_005433 |
| Gene Symbol | YES1 |
| Gene ID (NCBI) | 7525 |
| RRID | AB_10697656 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P07947 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
YES1, also named as p61-Yes and YES, belongs to the protein kinase superfamily, Tyr protein kinase family and SRC subfamily. It promotes infectivity of Neisseria gonorrhoeae in epithelial cells by phosphorylating MCP/CD46. YES1 catalyzes the reaction: ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. The antibody is specific to YES1.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for YES1-Specific antibody 20243-1-AP | Download protocol |
| IP protocol for YES1-Specific antibody 20243-1-AP | Download protocol |
| WB protocol for YES1-Specific antibody 20243-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The YES1-Specific Polyclonal antibody (Cat# 20243-1-AP) has 9 citations across journals including Nature, American Journal of Respiratory and Critical Care Medicine, Science Advances, Cell Death & Disease, Journal for ImmunoTherapy of Cancer, Cell Reports, iScience, and Journal of Cellular Biochemistry. Research fields span ageing and sirtuin biology, lung cancer, RNA polymerase II CTD phosphorylation, Alzheimer's disease, gastric cancer, NSCLC immunotherapy, glioblastoma, breast cancer, and ovarian cancer.
| Species | Application | Title |
|---|---|---|
Am J Respir Crit Care Med YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib. | ||
Sci Adv FeaSion decodes the regulatory landscape and functional diversity of RNA polymerase II CTD phosphorylation.
| ||
Sci Adv A brain proteomic signature of incipient Alzheimer's disease in young APOE ε4 carriers identifies novel drug targets. | ||
Cell Death Dis Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p. | ||
J Immunother Cancer SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.
|













